Cargando…
The dopamine transporter gene SLC6A3: multidisease risks
The human dopamine transporter gene SLC6A3 has been consistently implicated in several neuropsychiatric diseases but the disease mechanism remains elusive. In this risk synthesis, we have concluded that SLC6A3 represents an increasingly recognized risk with a growing number of familial mutants assoc...
Autores principales: | Reith, Maarten E. A., Kortagere, Sandhya, Wiers, Corinde E., Sun, Hui, Kurian, Manju A., Galli, Aurelio, Volkow, Nora D., Lin, Zhicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008071/ https://www.ncbi.nlm.nih.gov/pubmed/34650206 http://dx.doi.org/10.1038/s41380-021-01341-5 |
Ejemplares similares
-
Overview of the structure and function of the dopamine transporter and its protein interactions
por: Nepal, Binod, et al.
Publicado: (2023) -
SLC6 transporter oligomerization
por: Jayaraman, Kumaresan, et al.
Publicado: (2020) -
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019) -
Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder
por: Wang, Gene-Jack, et al.
Publicado: (2019) -
Increased transcription of TSPO, HDAC2, and HDAC6 in the amygdala of males with alcohol use disorder
por: De Carvalho, Luana Martins, et al.
Publicado: (2020)